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A method and bioreactor for the con-
tinuous production of synchronous
(same age) population of mammalian
cells have been invented. The invention
involves the attachment and growth of
cells on an adhesive-coated porous
membrane immersed in a perfused liq-
uid culture medium in a microgravity
analog bioreactor. When cells attach to
the surface divide, newborn cells are re-
leased into the flowing culture medium.
The released cells, consisting of a uni-
form population of synchronous cells
are then collected from the effluent cul-
ture medium. This invention could be
of interest to researchers investigating
the effects of the geneotoxic effects of
the space environment (microgravity,
radiation, chemicals, gases) and to
pharmaceutical and biotechnology
companies involved in research on
aging and cancer, and in new drug de-
velopment and testing.
The bioreactor includes a horizontal-
axis rotating vessel. A screen inside the
vessel supports the porous membrane
on which the cells are grown. A central
fluid coupler contains an inlet and an
outlet port with rotating seals for the cir-
culation of the culture medium. During
operation for the growth of cells, a peri-
staltic pump delivers the culture
medium from an external reservoir to
the input port. On its way from the inlet
to the outlet port, the culture medium
flows through the membrane, entrain-
ing newly released baby cells in the flow.
Once the culture medium has flowed
out of the simulated-low-gravity environ-
ment of the rotating vessel, the baby
cells are collected by allowing them to
settle out of the liquid under the influ-
ence of normal Earth gravitation.
Prior to operation for the growth of
cells, the membrane is coated with a cell
adhesive on the side designated to be
downstream during operation of the
bioreactor. This is done by filtering a so-
lution of adhesive through it in the re-
verse of the operational flow direction.
The membrane is then washed with a
similarly reversed flow of water or a
phosphate buffered saline solution.
Next, growing cells are applied to the
downstream side of the membrane by
means of a similarly reverse flow of a
medium containing a cell culture. These
reverse-flow operations for preparation
of the membrane can take place either
before or after the membrane is
mounted in the vessel: If membrane is
mounted in the vessel first, then the ad-
hesive solution, wash solution, and cul-
ture medium are simply pumped
through the vessel in the reverse of the
operational flow direction.
This work was done by Steve R. Gonda of
Johnson Space Center and Charles E. Helmstetter
and Maureen Thornton of Florida Institute of Tech-
nology. Further information is contained in a
TSP (see page 1).
In accordance with Public Law 96-517, the
contractor has elected to retain title to this inven-
tion. Inquiries concerning rights for its commer-
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